STOCK TITAN

Vivakor issues 3.17M shares in $730K debt conversion

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Vivakor, Inc. (VIVK) issued 3,170,000 common shares between November 12, 2026, and November 13, 2026, in exchange for conversion of $729,848 in principal and interest due under its convertible promissory notes. The notes were issued to two non-affiliate accredited investors.

The shares were issued without a Rule 144 restrictive legend, based on a legal opinion received by Vivakor and its transfer agent. Vivakor stated that the issuances were exempt from registration under Section 4(a)(2) of the Securities Act.

Filing Explained

The conversion is complete: Vivakor issued 3,170,000 shares for conversion of $729,848 in note principal and interest; issuing those shares increases the share count and reduces existing holders’ percentage ownership.

Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Common shares issued 3,170,000 shares Issued between November 12, 2026, and November 13, 2026, in exchange for conversion of principal and interest.
Principal and interest converted $729,848 Amount due under the convertible promissory notes exchanged for shares.
Aggregate note principal $15,000,000 Aggregate principal amount of notes issued May 7, 2026.
First tranche received $6,000,000 Received May 8, 2026, under the notes.
convertible promissory notes financial
"conversion of principal and interest due under its convertible promissory notes"
A convertible promissory note is a loan a company takes that can later be turned into shares instead of being paid back in cash; think of lending money now in exchange for a voucher that can become ownership later. Investors care because it mixes credit risk and potential ownership upside—it can protect lenders if a company struggles while also diluting existing shareholders when converted, affecting future share value and investor returns.
Rule 144 restrictive legend regulatory
"shares were issued without a Rule 144 restrictive legend"
Section 4(a)(2) regulatory
"exempt from registration under Section 4(a)(2) of the Securities Act"
Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.
accredited investors regulatory
"two non-affiliate accredited investors"
Accredited investors are individuals or entities considered to have enough financial knowledge and resources to understand and handle more complex and risky investments. They are often allowed to participate in private investment opportunities that are not available to the general public, similar to how experienced players might access exclusive clubs or events. This status helps ensure that investors can manage potential risks and rewards appropriately.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VIVK shares were issued in the debt conversion?

Vivakor issued 3,170,000 common shares in exchange for conversion of $729,848 in principal and interest due under the notes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001450704 0001450704 2026-11-12 2026-11-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 12, 2026

 

VIVAKOR, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-41286   26-2178141

(State or other jurisdiction of

incorporation or organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

5220 Spring Valley Road, Suite 500

Dallas, TX 75254

(Address of principal executive offices)

 

(469) 480-7175

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   VIVK   The Nasdaq Stock Market LLC
(Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Current Report on Form 8-K or this Report contains forward-looking statements. Any and all statements contained in this Report that are not statements of historical fact may be deemed forward-looking statements. Terms such as “may,” “might,” “would,” “should,” “could,” “project,” “estimate,” “pro-forma,” “predict,” “potential,” “strategy,” “anticipate,” “attempt,” “develop,” “plan,” “help,” “believe,” “continue,” “intend,” “expect,” “future” and terms of similar import (including the negative of any of the foregoing) may be intended to identify forward-looking statements. However, not all forward-looking statements may contain one or more of these identifying terms. Forward-looking statements in this Report may include, without limitation, statements regarding the plans and objectives of management for future operations.

 

The forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances, and may not be realized because they are based upon our current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which we have no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties.

 

Readers are cautioned not to place undue reliance on forward-looking statements because of the risks and uncertainties related to them. We disclaim any obligation to update the forward-looking statements contained in this Report to reflect any new information or future events or circumstances or otherwise, except as required by law.

 

1

 

  

Item 3.02 Unregistered Sales of Equity Securities.

 

As previously reported, on May 7, 2026, Vivakor, Inc. (the “Company”) issued convertible promissory notes (the “Notes”) to two non-affiliate, accredited investors (the “Investors”), in the aggregate principal amount of $15,000,000 (the “Principal Amount”), in relation to a Securities Purchase Agreement by and between the Company and the Investors (the “SPA”). On May 8, 2026, the Company received the first tranche of $6,000,000 under the Notes.

 

Between November 12, 2026 and November 13, 2026, the Company issued an aggregate of 3,170,000 shares (the “Investor Shares”) of its common stock in exchange for the conversion of $729,848 in principal and interest due under the Notes pursuant to Notices of Conversion from the Investors. Pursuant to the terms of the Notes and the Notices of Conversion, the Company issued the Investor Shares. The Investor Shares were issued without a Rule 144 restrictive legend pursuant to a legal opinion received by the Company and its transfer agent. The issuances of the foregoing securities were exempt from registration pursuant to Section 4(a)(2) of the Securities Act promulgated thereunder as the holder is an accredited investor and familiar with our operations.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VIVAKOR, INC.
     
Dated: November 18, 2026 By: /s/ James H. Ballengee
    Name:  James H. Ballengee
    Title: Chairman, President & CEO

 

3

 

Filing Exhibits & Attachments

3 documents

Keep reading